Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes | Zendy

Martin P. Ogrodzinski | Zendy; Shao Thing Teoh | Zendy; Sophia Y. Lunt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes

Author(s) -

Martin P. Ogrodzinski,

Shao Thing Teoh,

Sophia Y. Lunt

Publication year - 2020

Publication title -

cellular oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.698

H-Index - 40

eISSN - 2211-3436

pISSN - 2211-3428

DOI - 10.1007/s13402-020-00545-1

Subject(s) - targeted therapy , metabolomics , cancer research , cancer therapy , medicine , profiling (computer programming) , cancer , oncology , computational biology , bioinformatics , biology , computer science , operating system

Breast cancer is a heterogeneous disease with several subtypes that currently do not have targeted therapeutic options. Metabolomics has the potential to uncover novel targeted treatment strategies by identifying metabolic pathways required for cancer cells to survive and proliferate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research